Patients with high baseline diastolic blood pressure undergoing carotid endarterectomy are at increased risk of stroke, myocardial infarction, or death within 30 days of the procedure, according to results from the International Carotid Stenting Study (ICSS). In a paper published in the European Journal of Vascular and Endovascular Surgery, the authors say that in the context of a single preoperative measurement of blood pressure, diastolic blood pressure might be a better predictor than systolic blood pressure.
Data from the PYTHAGORAS (Prospective aneurysm trial: high angle Aorfix bifurcated stent graft) clinical trial suggest that the Aorfix (Lombard Medical) endograft remains the only on-label alternative to open abdominal aortic aneurysm repair for patients with highly angulated aortic necks, according to Mark Fillinger, Dartmouth Hitchcock Medical Center, Lebanon, USA, who presented the data at the 2015 VEITHsymposium (17–21 November, New York, USA).
The Supera peripheral stent offers the lowest risk of repeat procedures and is an “economically attractive” treatment for both payer and provider, according to a cost-effectiveness analysis presented at the 2015 VIVA meeting (2–5 November, Las Vegas, USA). The data were presented by Brian DeRubertis, University of California Los Angeles, USA.
Laminate Medical Technologies has announced the success of the first two German clinical cases using VasQ—an external support device for arteriovenous fistulas implanted during the fistula creation surgical procedure—following CE approval and 24 clinical cases completed at St George’s Hospital, London, UK.
The European Diagnostics Manufacturers Association (EDMA) and the European Medical Technology Industry (Eucomed) have approved a new joint code of conduct that stipulates that, after 31 December 2017, industry should no longer provide direct “financial or in kind support” to individual healthcare professionals to cover the costs of them attending third-party medical conferences. However, the new code does say that industry can provide educational grants to healthcare organisations to enable them to pay for physicians to attend conferences.
An interventional radiology technique shows promise for helping morbidly obese patients lose weight, according to the preliminary results of a study presented on 1 December 2015 at the annual meeting of the Radiological Society of North America (RSNA).
The AngioJet Zelante DVT thrombectomy catheter from Boston Scientific has received CE mark and US Food and Drug Administration (FDA) approval for the treatment of deep vein thrombosis (DVT) in large-diameter upper and lower limb peripheral veins.
Mubin I Syed, Dayton Interventional Radiology, Dayton, USA, presented on the early results of a pilot study designed is to achieve the collection of safety and efficacy data in patients undergoing left gastric artery embolization for morbid obesity at CIRSE 2015.
Miles Conrad, University of California San Francisco (UCSF), Interventional Radiology section and co-director of the UCSF HHT Centre of Excellence, spoke to Interventional News about a new device being investigated to embolize pulmonary arteriovenous malformations (PAVMs).
Gao-Jun Teng, Department of Radiology, Zhong-Da Hospital, Southeast University, Nanjing, China, presented on a novel stent that is loaded with 125 iodine seeds in malignancies at the “CIRSE meets China” session held at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) meeting in Lisbon, Portugal where he was made a Distinguished Fellow. Teng traced the development of this device from the bench to the bedside.
The first prospective, multicentre study of unselected patients undergoing percutaneous endovascular aortic aneurysm repair (EVAR) confirms previous findings of single-centre studies that the procedure is associated with a high technical success rate when performed by experienced operators.
Paulo Vilares Morgado, Interventional Radiology Unit, University Hospital S João, Porto, Portugal, presented the results of a prospective randomised controlled trial, AGIR (Angio-Seal in Interventional Radiology), at CIRSE 2015.
While presenting on the trials and updates in deep vein thrombosis, Stephen Kee, Professor of Radiology and Chief of Interventional Radiology, UCLA Health System in Los Angeles, speaking at CIRSE 2015, told delegates that there was “an information overload” when Pubmed was searched for “deep vein thrombosis”. There are over 65,000 articles online, he noted, with 42,000 relating to the treatment of the condition, 1,850 dealing with thrombolysis and 474 pertaining to aggressive therapy. “How do we make sense of all this data and what questions really need answering?” Kee asked.
A recent report by the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) which reviewed the care received by patients who had a severe gastrointestinal (GI) haemorrhage found that nearly half (49.5%) of the cases had clinical factors identified as leading to less than good care. In 18% of cases organisational factors were identified as contributing to less than good care. Some patients had deficiencies in both clinical and organisational factors.
The embolization of the superior rectal arteries, a procedure termed emborrhoid, has recently been shown to be effective in haemorrhoidal disease for patients who were treated on a compassionate basis.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos